Evotec SE (ETR:EVT - Get Free Report) shares dropped 4.4% on Friday . The stock traded as low as €6.68 ($7.68) and last traded at €6.71 ($7.71). Approximately 2,548,584 shares were traded during mid-day trading, an increase of 87% from the average daily volume of 1,360,000 shares. The stock had previously closed at €7.02 ($8.07).
Evotec Price Performance
The firm has a market capitalization of $1.29 billion, a P/E ratio of -7.52, a P/E/G ratio of 0.98 and a beta of 1.05. The company's 50-day simple moving average is €6.67 and its two-hundred day simple moving average is €7.70.
About Evotec
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
See Also
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
